In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Tanabe, Taisho terminate merger agreement

Executive Summary

Japan's eighth largest drug company Taisho Pharmaceutical will merge with the tenth largest, Tanabe Seiyaku. The companies will operate under a holding company, Taisho Tanabe Pharma Group, to become the country's third largest drug developer. Taisho shareholders will get one share in the new company for each share they hold and Tanabe shareholders will receive 0.55 shares in the new company for each of their shares.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies